TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Correction of Baumann's angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maximum diarrhea severity
Endpoint domain: Adverse events/effects
Primary endpoint: Balloon insertion to delivery interval
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vaginal delivery rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Inhibition of FVIII:C
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Endogenous thrombin potential reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Total remission of anal fissures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Moderate/severe diarrhea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Treatment interruption (mean days)
Endpoint domain: Resource use
Primary endpoint: Number of supportive medication
Endpoint domain: Resource use
Primary endpoint: Weighted-mean glucose area under the curve (AUC) reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: active motor threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: functional domain of upper limbs of SS-QOL
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: adductor muscle asymmetry
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: CK-MB elevation >16 U/L
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Peak creatine phosphokinase level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Richness and diversity of fecal samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relative abundance of Proteobacteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relative abundance of Faecalibacterium and Ruminococcus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Primary mechanical hyperalgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Secondary heat hyperalgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical FM pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of iris neovascularization (NVI)
Endpoint domain: Adverse events/effects
Primary endpoint: Total Plaque Volume (TPV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Dyscoordination of swallowing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Transit time of bolus from pharynx to esophagus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Number of drinks consumed per heaviest drinking week
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of heavy episodic drinking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceived discrepancy between self and others' drinking
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Frisén score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: disc area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ONH volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment success at day one
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EEG power in the frontal polar region
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: mean SNOT-20 scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AV interval optimization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: VV interval optimization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Traumatic birth perception
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean MARI for heart attack/stroke
Endpoint domain: Adverse events/effects
Primary endpoint: Mean MARI for stomach bleed
Endpoint domain: Adverse events/effects
Primary endpoint: Mean MARI for hypertension
Endpoint domain: Adverse events/effects
Primary endpoint: Mean MARI for fluid retention
Endpoint domain: Adverse events/effects
Primary endpoint: Mean MARI for dyspepsia
Endpoint domain: Adverse events/effects
Primary endpoint: Toxicity observed
Endpoint domain: Adverse events/effects
Primary endpoint: Target AUC of carboplatin achieved
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak concentration of paclitaxel
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Count of NK cells (CD3‐, CD16+) in the peripheral blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Lack of culturally competent care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: High cost of care
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Uncertainty associated with genetic testing
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Risk of death without recurrence
Endpoint domain: Mortality/survival
Primary endpoint: Physical exhaustion
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Bleeding during the operation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Amount of distention medium required
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Incidence of acute neurotoxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of grade 1-2 chronic neurotoxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of grade 1-2 neuropathy
Endpoint domain: Adverse events/effects
Primary endpoint: Employment status change
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Varus laxity measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Valgus laxity measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Area under the curve of GH (AUC(GH)) during exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: increase in mean tissue temperature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success rate of venous access
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-reported patient discomfort (VAS scores)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Complications related to venous access
Endpoint domain: Adverse events/effects
Primary endpoint: Incident cases of tuberculosis
Endpoint domain: Adverse events/effects
Primary endpoint: Corticocapsular separation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Early fragment removal
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Progression of femoral artery atherosclerosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Albumin-creatinine ratio (ACR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Mean left ventricular fractional shortening z scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: high and low end-state functioning
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Postoperative ventilation requirement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Cost-effectiveness of hand exercises
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Quality of life improvement (MRC, CAT)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Lung function improvement (FVC, FEV1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: time until wake-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total time for anesthesia and recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: restlessness and agitation
Endpoint domain: Adverse events/effects
Primary endpoint: V̇O2 max
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognitive decline measured by TMT B–A
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Cognitive decline measured by COWAT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: performance of stroke risk-related behaviors
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: personal risk factor recall
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: general risk factor recall
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: psychomotor developmental index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean body length
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Completion of therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: adherence to home practice frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ventilation distribution
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Regional impedance amplitudes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Global inhomogeneity indices
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Incremental Area Under the Curve (IAUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: depression history taking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in bone alkaline phosphatase (bALP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportion of patients achieving EASI 50
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients achieving EASI 75
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in pruritus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amount of soft tissue formed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amount of new bone formation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of neurological complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Lysozyme levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum delta-tocotrienol level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: liver function parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: kidney function parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in the need for postoperative interventions
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: retention rates
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: drop-out
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: sexual function
Endpoint domain: Life impact
Endpoint subdomain: Sexual functioning
Primary endpoint: marital intimacy
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Left ventricular Tei index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: PGA-OA scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total adipose tissue (TAT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Duration of joint swelling, arthralgia, and purpura
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of urinary beta2‐MG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Six-month recurrent rate
Endpoint domain: Adverse events/effects
Primary endpoint: sustained abstinence between 6 and 12 months postpartum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: excellent analgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Whole-gut transit time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: pH across the ileocaecal junction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: maximum dermatitis during RT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: myocardial flow reserve
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: post-operative comfort
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: alveolar height and width changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: student self‐ratings of communication competence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Event-free survival (EFS) at 5 years
Endpoint domain: Mortality/survival
Primary endpoint: CAP rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Sleep
Primary endpoint: sleep quality
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Decrease of serum concentration of bilirubin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Activities of transaminases and alkaline phosphatase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hepatomegaly reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood creatinine levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Urine creatinine and album levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: FIMR grade
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of grade‐4 hematologic toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: MDI-use score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DPI-use score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Distribution of ferristene in the small bowel
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Protocol adherence
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Duration of disability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: INR of 2.0 to 3.0 by day 4 or 5 of therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time from injection of NMB reversal agents to gas-out time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Improvement in retinal perfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Worsening in retinal perfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effective compressions in 10 min
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: No-flow fraction while driving on curved sections
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Protein balance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Insulin resistance (M value)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oxygen uptake at rest
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Oxygen kinetics (tau) during exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Concentric isokinetic knee strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Concentric isokinetic knee power
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Diagnostic accuracy for detection of CHD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Sensitivity for localization of stenosed vessels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: ADD increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood lactate monitoring accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Provision of fresh fruits and vegetables to children
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HOMA-IR (Homeostasis Model Assessment Index)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Larynx exposure success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Guideline-concordant prescribing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: six-month continuous abstinence quit rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of BPF development
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of empyema
Endpoint domain: Adverse events/effects
Primary endpoint: Simulator performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: shrinkage of bone dimensions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Onset of depressive episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Homocysteine (Hcy) level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: High-sensitivity C-reactive protein (hsCRP) level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total duration of reflux
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Gastric emptying times
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Levels of TBIL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Levels of ALT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Unfavorable structural outcome at 3 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intravariceal pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Variceal pressure gradient
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Estimated variceal wall tension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: serum 25(OH)D level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rebleeding within 30 days
Endpoint domain: Adverse events/effects
Primary endpoint: HBV DNA response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: graft height loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Heart Rate Variability (HRV) measure pNN50
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Improvement of knowledge, attitudes and perceived ability to act in tobacco control
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Contrast sensitivity under scotopic conditions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ocular wavefront aberration (4th-order RMS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ocular wavefront aberration (total higher-order RMS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: brain atrophy metrics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: N‐acetylaspartate levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: spinal cord atrophy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Regulating immune and endocrinal function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Improvement of various symptoms of aging
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: CPT‐II performance improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Digit Span memory performance improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection of vascular pathology
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: composite neonatal outcome
Endpoint domain: Mortality/survival
Primary endpoint: Proportions of bifidobacteria in the maternal gut
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes